SV

Sonam Verma

Active Director Director DIN 08279060
DIN 08279060 First appointment Nov 2018 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2018
Shareholding value •••• Premium profile

About Sonam Verma

Data last updated:

Sonam Verma is a Director at Mugass Pharma Private Limited (since 2018). The company operates in Business Services. Mugass Pharma Private Limited reported revenue of ₹55,790 (FY 2025).

DIN 08279060
Primary Designation Director
Industry Business Services
First Appointment 14 Nov 2018
Oldest Company Age 8 yrs
Largest company Mugass Pharma Private Limited · ₹55,790 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mugass Pharma Private Limited U74999UP2018PTC110281
Director14 Nov 20182018₹55,790 (FY 2025)Active

Board colleagues of Sonam Verma

NameDINCompanyDesignation
Saurabh Verma08279059Mugass Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mugass Pharma Private Limited
Premium access

Shareholding and investment profile for Sonam Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sonam Verma

Sonam Verma currently holds 1 directorship: Mugass Pharma Private Limited (Director, since 14 Nov 2018, revenue ₹55,790 (FY 2025)).

Sonam Verma was first appointed on 14 Nov 2018 as Director at Mugass Pharma Private Limited.

The current boards of Sonam Verma's companies include Saurabh Verma (Mugass Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available